Maintaining Bone Health in Prostate Cancer Throughout the Disease Continuum
Authors:
- Fred SaadFred Saad
- James EasthamJEJames Eastham
- 30 June 2010
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 37, S30-S37
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Pathologic fractures correlate with reduced survival in patients with malignant bone diseaseCancer, 2007
- Treatment-Related Osteoporosis in Men with Prostate CancerClinical Cancer Research, 2006
- EAU Guidelines on Prostate CancerEuropean Urology, 2005
- The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancerAnnals of Oncology, 2005
- Long-Term Efficacy of Zoledronic Acid for the Prevention of Skeletal Complications in Patients With Metastatic Hormone-Refractory Prostate CancerJNCI: Journal of the National Cancer Institute, 2004
- Androgen deprivation in men with prostate cancer is associated with an increased rate of bone lossProstate Cancer and Prostatic Diseases, 2002
- Bone Loss following Hypogonadism in Men with Prostate Cancer Treated with GnRH AnalogsThe Journal of Clinical Endocrinology & Metabolism, 2002
- Metastatic bone disease: clinical features, pathophysiology and treatment strategiesCancer Treatment Reviews, 2001
- Cellular and molecular mechanisms of action of bisphosphonatesCancer, 2000
- Skeletal complications of malignancyCancer, 1997